Talis Biomedical Corp. develops and commercializes innovative products that are designed to enable accurate, reliable, low cost and rapid molecular testing for infectious diseases. The company is headquartered in Chicago, Illinois and currently employs 99 full-time employees. The company went IPO on 2021-02-12. The firm is focused on advancing health equity and outcomes through the delivery of accurate infectious disease testing in the moment of need, at the point of care.

Industry: Laboratory Analytical Instruments Peers: Abbott Laboratories Aspira Women's Health Inc Conformis Inc Microbot Medical Inc IRIDEX Corp Milestone Scientific Inc Nemaura Medical Inc. Scientific Industries Inc VAPOTHERM INC